Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)NBT-NM108 as an Early Treatment for Suspected or Confirmed Symptomatic COVID-19 Patients
Phase 2
Completed
- Conditions
- Suspected or Confirmed COVID-19
- Interventions
- Other: Usual Care Only
- First Posted Date
- 2020-09-07
- Last Posted Date
- 2024-10-07
- Lead Sponsor
- Notitia Biotechnologies Company
- Target Recruit Count
- 42
- Registration Number
- NCT04540406
- Locations
- 🇺🇸
University of South Florida Morsani College of Medicine, Tampa, Florida, United States
News
No news found